Literature DB >> 20658355

Aspirin resistance in hemodialysis patients.

Abdallah Sassine Geara, Nassif Azzi, Claude Bassil, Suzanne El-Sayegh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20658355     DOI： 10.1007/s11255-010-9811-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  15 in total

1.  Comparison of a rapid platelet function assay--Verify Now Aspirin--with whole blood impedance aggregometry for the detection of aspirin resistance.

Authors:  Anna M Dyszkiewicz-Korpanty; Anne Kim; James D Burner; Eugene P Frenkel; Ravindra Sarode
Journal:  Thromb Res       Date:  2007-01-16       Impact factor: 3.944

Review 2.  The CARI guidelines. Pharmacological approaches to preventing vascular access failure.

Authors:  Kevan Polkinghorne
Journal:  Nephrology (Carlton)       Date:  2008-07       Impact factor: 2.506

Review 3.  Assessing the current role of platelet function testing.

Authors:  Eugene Braunwald; Dominick Angiolillo; Eric Bates; Peter B Berger; Deepak Bhatt; Christopher P Cannon; Mark I Furman; Paul Gurbel; Alan D Michelson; Eric Peterson; Stephen Wiviott
Journal:  Clin Cardiol       Date:  2008-03       Impact factor: 2.882

Review 4.  Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.

Authors:  Wiktor Kuliczkowski; Adam Witkowski; Lech Polonski; Cezary Watala; Krzysztof Filipiak; Andrzej Budaj; Jacek Golanski; Dariusz Sitkiewicz; Jerzy Pregowski; Jacek Gorski; Marian Zembala; Grzegorz Opolski; Kurt Huber; Harald Arnesen; Steen D Kristensen; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2009-01-27       Impact factor: 29.983

Review 5.  Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.

Authors:  George Krasopoulos; Stephanie J Brister; W Scott Beattie; Michael R Buchanan
Journal:  BMJ       Date:  2008-01-17

6.  Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.

Authors:  R F Spurney; P Y Fan; P Ruiz; F Sanfilippo; D S Pisetsky; T M Coffman
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

7.  Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.

Authors:  E A Lianos; G A Andres; M J Dunn
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

8.  Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients.

Authors:  S Acikel; A Yildirir; A Aydinalp; K Demirtas; U Bal; G Kaynar; B Ozin; H Karakayali; H Muderrisoglu; M Haberal
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

9.  Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients.

Authors:  Tetsuya Ogawa; Hideki Ishida; Mayuko Akamatsu; Nami Matsuda; Ayuko Fujiu; Kyoko Ito; Yoshitaka Ando; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2009-05-09       Impact factor: 2.370

10.  Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.

Authors:  Wai-Hong Chen; Pui-Yin Lee; William Ng; Hung-Fat Tse; Chu-Pak Lau
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094
View more
  2 in total

1.  Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease.

Authors:  Hadar Haim-Pinhas; Gil Yoskovitz; Michael Lishner; David Pereg; Yona Kitay-Cohen; Guy Topaz; Yaron Sela; Ori Wand; Ilan Rozenberg; Sydney Benchetrit; Keren Cohen-Hagai
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

Review 2.  Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.

Authors:  Joonseok Kim; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.